SCHRODER INVESTMENT MANAGEMENT GROUP - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 88 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q1 2021. The put-call ratio across all filers is 0.04 and the average weighting 0.8%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2021$73,000
-54.9%
615
-55.0%
0.00%
Q4 2020$162,000
+113.2%
1,368
+100.0%
0.00%
Q3 2020$76,000
-37.2%
684
-42.2%
0.00%
Q2 2020$121,000
+24.7%
1,184
+20.7%
0.00%
Q1 2020$97,000
-24.2%
981
-10.7%
0.00%
Q4 2019$128,000
-98.0%
1,098
-98.4%
0.00%
-100.0%
Q2 2018$6,502,000
-37.5%
67,320
-47.6%
0.01%
-38.9%
Q1 2018$10,402,000
-30.5%
128,420
-32.4%
0.02%
-25.0%
Q4 2017$14,960,000189,9200.02%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q1 2021
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 137,557$11,142,0006.62%
COMGEST GLOBAL INVESTORS S.A.S. 637,752$51,658,0001.13%
Black Creek Investment Management Inc. 411,525$33,334,0001.09%
Hillhouse Capital Management 618,391$50,090,0000.88%
RUDMAN ERROL M 21,301$1,725,0000.83%
JUPITER ASSET MANAGEMENT LTD 263,705$21,360,0000.65%
York Capital Management Global Advisors, LLC 341,616$27,671,0000.62%
VONTOBEL ASSET MANAGEMENT INC 873,968$71,525,0000.51%
Temasek Holdings (Private) Ltd 990,000$80,190,0000.44%
WASATCH ADVISORS LP 292,216$23,669,0000.31%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders